Free Trial

Cognex Corporation $CGNX Shares Sold by TD Asset Management Inc

Cognex logo with Computer and Technology background

Key Points

  • TD Asset Management Inc has reduced its stake in Cognex Corporation by 51.5%, now holding approximately 353,268 shares valued at $11.2 million.
  • During the same period, other institutional investors like T. Rowe Price and Mackenzie Financial significantly increased their stakes, reflecting ongoing interest from large investors in Cognex's stock.
  • Cognex reported earnings of $0.25 per share for the last quarter, exceeding the consensus estimate, with revenues growing by 4.2% year-over-year.
  • Five stocks we like better than Cognex.

TD Asset Management Inc trimmed its holdings in shares of Cognex Corporation (NASDAQ:CGNX - Free Report) by 51.5% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 353,268 shares of the scientific and technical instruments company's stock after selling 375,018 shares during the period. TD Asset Management Inc owned approximately 0.21% of Cognex worth $11,206,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of CGNX. T. Rowe Price Investment Management Inc. boosted its stake in Cognex by 32.0% during the first quarter. T. Rowe Price Investment Management Inc. now owns 6,082,319 shares of the scientific and technical instruments company's stock valued at $181,436,000 after buying an additional 1,474,832 shares in the last quarter. Mackenzie Financial Corp boosted its stake in Cognex by 126.2% during the first quarter. Mackenzie Financial Corp now owns 4,609,802 shares of the scientific and technical instruments company's stock valued at $137,510,000 after buying an additional 2,571,457 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its stake in Cognex by 34.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 2,539,557 shares of the scientific and technical instruments company's stock valued at $75,756,000 after buying an additional 647,955 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in Cognex by 1.9% during the first quarter. Bank of New York Mellon Corp now owns 2,131,538 shares of the scientific and technical instruments company's stock valued at $63,584,000 after buying an additional 38,857 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in Cognex by 5.6% during the first quarter. Charles Schwab Investment Management Inc. now owns 1,507,022 shares of the scientific and technical instruments company's stock valued at $44,954,000 after buying an additional 79,266 shares in the last quarter. 88.12% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Cognex

In related news, EVP Sheila Marie Dipalma sold 2,000 shares of the stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $45.03, for a total value of $90,060.00. Following the completion of the sale, the executive vice president directly owned 6,582 shares of the company's stock, valued at approximately $296,387.46. This represents a 23.30% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 1.60% of the company's stock.

Cognex Trading Down 0.6%

Shares of Cognex stock opened at $46.04 on Friday. The stock has a 50-day moving average price of $44.62 and a 200 day moving average price of $35.46. The company has a market cap of $7.73 billion, a P/E ratio of 64.85 and a beta of 1.50. Cognex Corporation has a 1 year low of $22.67 and a 1 year high of $47.52.

Cognex (NASDAQ:CGNX - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.23 by $0.02. The firm had revenue of $249.09 million during the quarter, compared to the consensus estimate of $246.70 million. Cognex had a return on equity of 6.65% and a net margin of 13.13%.The business's revenue for the quarter was up 4.2% on a year-over-year basis. During the same period in the prior year, the business earned $0.23 EPS. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS. On average, equities analysts forecast that Cognex Corporation will post 0.61 earnings per share for the current fiscal year.

Cognex Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 28th. Investors of record on Thursday, August 14th were paid a $0.08 dividend. This represents a $0.32 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend was Thursday, August 14th. Cognex's dividend payout ratio is currently 45.07%.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on CGNX shares. UBS Group raised their target price on Cognex from $53.00 to $58.00 and gave the company a "buy" rating in a research note on Friday, August 1st. JPMorgan Chase & Co. started coverage on Cognex in a research note on Monday, September 15th. They set a "neutral" rating and a $45.00 target price for the company. Needham & Company LLC raised their target price on Cognex from $36.00 to $45.00 and gave the company a "buy" rating in a research note on Thursday, July 31st. Weiss Ratings reiterated a "hold (c)" rating on shares of Cognex in a research report on Wednesday, October 8th. Finally, Truist Financial set a $45.00 price target on Cognex and gave the company a "hold" rating in a research report on Wednesday, October 8th. Two investment analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $44.93.

Check Out Our Latest Research Report on CGNX

Cognex Profile

(Free Report)

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.

Read More

Institutional Ownership by Quarter for Cognex (NASDAQ:CGNX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cognex Right Now?

Before you consider Cognex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cognex wasn't on the list.

While Cognex currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.